NASDAQ:ACOR - Acorda Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$11.33 +0.41 (+3.75 %)
(As of 04/24/2019 03:49 AM ET)
Previous Close$10.92
Today's Range$10.7350 - $11.45
52-Week Range$10.55 - $36.35
Volume682,511 shs
Average Volume872,296 shs
Market Capitalization$539.68 million
P/E Ratio6.23
Dividend YieldN/A
Beta1.47

Analyst Ratings

Acorda Therapeutics (NASDAQ:ACOR) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
9 Wall Street analysts have issued ratings and price targets for Acorda Therapeutics in the last 12 months. Their average twelve-month price target is $21.25, suggesting that the stock has a possible upside of 87.56%. The high price target for ACOR is $33.00 and the low price target for ACOR is $10.00. There are currently 2 sell ratings, 5 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.002.002.102.15
Ratings Breakdown: 2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
2 Sell Rating(s)
5 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
9 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $21.25$21.25$24.3333$23.3636
Price Target Upside: 87.56% upside48.08% upside53.14% upside27.95% upside

Acorda Therapeutics (NASDAQ:ACOR) Consensus Price Target History

Price Target History for Acorda Therapeutics (NASDAQ:ACOR)

Acorda Therapeutics (NASDAQ:ACOR) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/19/2019OppenheimerReiterated RatingHoldHighView Rating Details
2/15/2019Cantor FitzgeraldReiterated RatingHold$20.00HighView Rating Details
1/23/2019HC WainwrightSet Price TargetBuy$33.00LowView Rating Details
1/7/2019CowenReiterated RatingBuy$30.00MediumView Rating Details
1/2/2019JPMorgan Chase & Co.Reiterated RatingHoldHighView Rating Details
12/26/2018Raymond JamesReiterated RatingSellMediumView Rating Details
12/11/2018Goldman Sachs GroupDowngradeNeutral ➝ Sell$19.00 ➝ $10.00HighView Rating Details
11/4/2018Jefferies Financial GroupReiterated RatingHold$22.00MediumView Rating Details
10/5/2018Stifel NicolausLower Price TargetHold ➝ Hold$25.00 ➝ $19.00HighView Rating Details
2/15/2018Piper Jaffray CompaniesUpgradeNeutral ➝ Overweight$25.10 ➝ $37.00HighView Rating Details
11/16/2017Janney Montgomery ScottSet Price TargetHold$26.00 ➝ $17.00N/AView Rating Details
11/15/2017Leerink SwannLower Price TargetMarket Perform$18.00N/AView Rating Details
11/9/2017CIBCInitiated CoverageMarket Perform ➝ Market PerformN/AView Rating Details
(Data available from 4/24/2017 forward)
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel